Gavi [to 6 February 2016]
http://www.gavialliance.org/library/news/press-releases/

.
05 February 2016
Study shows near elimination of Hib disease in Kilifi region of Kenya after introduction of vaccine
Welcome Trust and Gavi funded research also shows Hib booster not needed for long-term protection.

Geneva – Research funded by the Wellcome Trust and Gavi, the Vaccine Alliance has provided compelling new evidence that three doses of Haemophilus influenzae type b (Hib) vaccine can give children in low-income countries long-lasting protection against life-threatening disease..

Published in the journal Lancet Global Health today, the study was carried out in the Kilifi region of Kenya over a period of 15 years…